Cargando…

OR17-01 Leptin Decreases De Novo Lipogenesis in Lipodystrophic Patients

De novo lipogenesis (DNL) plays a role in the development of hepatic steatosis and non-alcoholic fatty liver disease (NAFLD). In rodent models of both health and lipodystrophy (LD), leptin decreases DNL. In human patients with LD, reduced adipose tissue results in adipokine deficiencies, including l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baykal, Annah Petek, Parks, Elizabeth J, Shamburek, Robert, Chung, Stephanie, Syed-Abdul, Majid M, Muniyappa, Ranganath, Cochran, Elaine, Startzell, Megan, Gharib, Ahmed M, Ouwerkerk, Ronald, Walter, Peter J, Brown, Rebecca J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Cardiovascular Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207974/ http://dx.doi.org/10.1210/jendso/bvaa046.035

Ejemplares similares

SAT-081 Advanced Lipoprotein Analysis Demonstrates Atherogenic Lipid Profile in Patients with Lipodystrophy That Improves after Metreleptin Treatment
por: Kinzer, Alexandra, et al.
Publicado: (2019)

Leptin treatment has vasculo-protective effects in lipodystrophic mice
por: Stürzebecher, Paulina Elena, et al.
Publicado: (2022)

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII
por: Brite, Brianna, et al.
Publicado: (2021)

SUN-087 Effects of Leptin Replacement on Circulating Plasma Inhibitors of Lipoprotein Lipase in Patients with Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2019)

Leptin Improves Parameters of Brown Adipose Tissue Thermogenesis in Lipodystrophic Mice
por: Hoffmann, Annett, et al.
Publicado: (2021)

FRI099 Advanced Lipoprotein Analysis In Patients With Cushing’s Syndrome
por: Varghese, Ron T, et al.
Publicado: (2023)

Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience
por: Araujo-Vilar, David, et al.
Publicado: (2014)

Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy
por: Muniyappa, Ranganath, et al.
Publicado: (2014)

Lipodystrophic laminopathies: Diagnostic clues
por: Guillín-Amarelle, Cristina, et al.
Publicado: (2018)

Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis
por: Podszun, Maren C., et al.
Publicado: (2020)

SUN-565 The Effect of Leptin Treatment on Blood Pressure and Autonomic Nervous System Function in Patients with Lipodystrophy
por: Grover, Andrew, et al.
Publicado: (2020)

Irisin levels in LMNA-mutated lipodystrophic syndromes
por: Bensmaine, Faiza, et al.
Publicado: (2015)

Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice
por: Wilson, Anne, et al.
Publicado: (2018)

Myostatin inhibition improves hyperglycemia and hyperphagia in lipodystrophic mice
por: Guo, Tingqing, et al.
Publicado: (2012)

Activation of Sphingolipid Pathway in the Livers of Lipodystrophic Agpat2(−/−) Mice
por: Sankella, Shireesha, et al.
Publicado: (2017)

De Novo Lipogenesis Products and Endogenous Lipokines
por: Yilmaz, Mustafa, et al.
Publicado: (2016)

DAXX drives de novo lipogenesis and contributes to tumorigenesis
por: Mahmud, Iqbal, et al.
Publicado: (2023)

Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis
por: Harding, Scott V, et al.
Publicado: (2015)

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019)

Expanding Roles of De Novo Lipogenesis in Breast Cancer
por: Simeone, Pasquale, et al.
Publicado: (2021)

MON-611 Biux2x2
por: Kushchayeva, Yevgeniya, et al.
Publicado: (2019)

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015)

OR08-04 Differences in Advanced Lipoprotein Profile Between Rabson-Mendenhall Syndrome and Lipodystrophy
por: Al-Jundi, Mohammad, et al.
Publicado: (2020)

OR18-04 Leptin Decreases Gluconeogenesis And Gluconeogenic Substrate Availability In Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2023)

Modeling fructose-load-induced hepatic de-novo lipogenesis by model simplification
por: Allen, Richard J, et al.
Publicado: (2017)

Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis
por: Valtolina, Chiara, et al.
Publicado: (2019)

Surplus fat rapidly increases fat oxidation and insulin resistance in lipodystrophic mice
por: Girousse, Amandine, et al.
Publicado: (2018)

Lipodystrophic laminopathy: Lamin A mutation relaxes chromatin architecture to impair adipogenesis
por: Elzeneini, Eman, et al.
Publicado: (2017)

SUN-037 Diagnosis Challenge in Type 4 Familial Partial Lipodystrophic Syndrome
por: Vantyghem, Marie-Christine, et al.
Publicado: (2019)

Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells
por: Bowlby, Sarah C., et al.
Publicado: (2012)

Direct Visualization of De novo Lipogenesis in Single Living Cells
por: Li, Junjie, et al.
Publicado: (2014)

Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat
por: Song, Kangxing, et al.
Publicado: (2014)

Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
por: Song, Ziyi, et al.
Publicado: (2018)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

Fructose drives de novo lipogenesis affecting metabolic health
por: Geidl-Flueck, Bettina, et al.
Publicado: (2023)

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
por: Hazlehurst, Jonathan M., et al.
Publicado: (2022)

The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
por: Moore, J. Bernadette, et al.
Publicado: (2014)

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2021)

Dietician-based approach to lipodystrophic syndrome: role of bioelectrical impedance analysis at week 12
por: Orofino, G, et al.
Publicado: (2010)

Defective Differentiation of Adipose Precursor Cells from Lipodystrophic Mice Lacking Perilipin 1
por: Lyu, Ying, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d0s8oohtksdckeh3m7i5fm0aak